Okay so the reason tren and anadrol hits so different isn’t just that they’re both strong. It’s that they’re working through completely different pathways and not fighting each other for the same receptors.

There’s basically 3 places the androgen receptor sits on the cell. The classic one, binds the androgen, goes to the nucleus, drives gene transcription and protein synthesis, that’s the main pathway and that’s where most of your growth comes from. Then there’s one that stays on the cell surface and doesn’t do gene transcription at all, that’s the non genomic stuff. And then a subcellular one that almost nothing touches, winstrol and danazol are basically the only compounds that interact with it and nobody really knows what it’s doing.

So you can split gear into 2 classes.

Class 1 works through the classic AR. Test (though test is the only one with fully mixed activity, genomic and non genomic both), EQ, primo, nandrolone, tren. Masteron is unclear, it’s barely been studied.

Class 2 has little or no AR affinity and works through other routes. Anadrol (literally no known affinity for the androgen receptor), dbol, winstrol.

Here’s why stacking within a class does nothing much. You add EQ to your test, that’s one plus one on the same pathway. You’re just hitting the AR over and over with the same key. You’re not getting anything you couldn’t have got by just running more test, and you’re probably getting less because they’re competing for the same finite pool of receptors. Same deal adding primo or mast. There’s very little primo does that test doesn’t already do.

Now tren and anadrol is a different thing entirely because they’re the strongest compound in each class and they’re not stepping on each other.

Tren is the most potent class 1 there is. Lower KD value, meaning it binds the AR way tighter than test, EQ, Mast or Primo and it doesn’t get converted down into weaker metabolites the way test does. Plus it’s strongly anti catabolic and partitions nutrients, which is exactly why it works so well in a deficit where everything else struggles.

Anadrol has no known AR affinity at all. It’s working through non AR routes including direct estrogen receptor activation. So it’s not competing with the tren for receptor space, it’s doing its thing somewhere else completely.

So you end up with two separate pathways maxed at the same time instead of one saturated pathway. 50 mg of anadrol plus 50 mg of tren does more than 100 mg of either on its own. Anyone who’s run both together knows the growth is noticeably different to adding primo to tren.

If you wanted to cover every base it’d be test as the base, tren for the classic AR, anadrol for the non AR, winstrol for the subcellular one.

One more thing worth knowing. New androgen receptors get made during the translation stage of protein synthesis, and translation is the one stage that actually needs energy. So if you’re in a deficit you’re limiting how many new AR you make. Tren might partly outwork that, which is another reason it earns its spot in a cutting stack when other stuff doesn’t.

Now the caveats because I’m not going to pretend this is settled science.

The class 1 and 2 thing is dated and oversimplified. Real androgen signalling is a spectrum of binding affinities and a bunch of different non genomic mechanisms, not two neat boxes. The DHT derived orals especially don’t fit cleanly.

And the synergy being real doesn’t mean you should run it. To get it you need the harsh orals, and the potency and the toxicity come from the same place. That’s competitor logic. For most people test, primo and GH covers what you actually need. I ran tren and anadrol, it worked exactly like the theory says, and I’m not doing it again.

Absolutely spiked my prolactin to hell, started getting ichy nipples. Thankfully I was prepared. Even though I was prepared l-tyrosine, p5p, masteron on hand and finally caber. The nipples sensitivity continued even when prolactin was back in range.
What completely stopped all of the sides is tamoxifen 20 mg split morning evening.